Advertisement
UK markets close in 31 minutes

  • FTSE 100

    8,137.17
    +58.31 (+0.72%)
     

  • FTSE 250

    19,814.81
    +212.83 (+1.09%)
     

  • AIM

    755.39
    +2.27 (+0.30%)
     

  • GBP/EUR

    1.1669
    +0.0012 (+0.10%)
     

  • GBP/USD

    1.2459
    -0.0052 (-0.41%)
     

  • Bitcoin GBP

    51,219.86
    +481.93 (+0.95%)
     

  • CMC Crypto 200

    1,332.60
    -63.93 (-4.58%)
     

  • S&P 500

    5,103.01
    +54.59 (+1.08%)
     

  • DOW

    38,198.52
    +112.72 (+0.30%)
     

  • CRUDE OIL

    83.46
    -0.11 (-0.13%)
     

  • GOLD FUTURES

    2,345.90
    +3.40 (+0.15%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,168.06
    +250.78 (+1.40%)
     

  • CAC 40

    8,103.68
    +87.03 (+1.09%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

BUZZ-GlaxoSmithKline: hit as 2015 gloom outweighs long-term hope

Reuters - UK Focus

** GlaxoSmithKline (Other OTC: GLAXF - news) second biggest FTSE 100 faller, down 3.4 pct, as analysts downgrade near-term estimates after drugmaker warns of "high teens" percentage fall in 2015 EPS

** Brokerages Bernstein and Bryan Garnier both cut price targets. Bernstein analyst Tim Anderson says 2015 guidance "much worse than our modeling of -5 pct or consensus of -11 pct"

** GSK argued at May 6 investor day it was taking short-term hit in 2015, but expected long-term gain as it reshapes business to ensure reliable growth and secure dividend

(RM (LSE: RM.L - news) : ben.hirschler.thomsonreuters.com@reuters.net)